Legend Biotech Corp ADR (LEGN)

Overview News Price History Option Chain Why LEGN Down? Discussions Forecast

Why is Legend Biotech Corp ADR (LEGN) Stock down?

We've noticed a 5.02% decline in Legend Biotech Corp ADR (LEGN) stock during the 2024-04-16 trading session. While this could be attributed to normal volatility or various internal and external factors, please be aware that we are actively monitoring the situation, and we'll provide timely updates as soon as possible!

21 Nov, 2023:

Legend Biotech Corp Stock (LEGN) dropped by 5.37% from $60.50 to $57.25 in the trading on Tuesday November 21, 2023. The reasons why LEGN stock down today include:

Mixed third-quarter results: Legend Bio reported third quarter EPS of $-0.17, $0.14 better than the analyst estimate of $-0.31. Revenue for the quarter came in at $96.01M versus the consensus estimate of $97.42M.
New Competitors: Arcellx’s CART-ddBCMA emerged as a strong competitor in the CAR-T MM market, Arcellx’s CART-ddBCMA has shown promising efficacy and safety data, positioning it as a viable alternative to Carvykti.